Release Date: 08/08/18 08:23 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 101.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%